Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency

Fig. 1

Trial profile. G6PD status was determined initially using the fluorescent spot test (FST). At Anlong Venh and Veal Veng, only FST-diagnosed G6PDd patients were recruited. Final G6PD status shown here is based on G6PD enzyme activity and G6PD genotype. DHAPP dihydroartemisinin/piperaquine, G6PD glucose-6-phosphate dehydrogenase

Back to article page
\